SS-31 (Elamipretide): The Mitochondria-Targeted Peptide at the Frontier of Aging Research

SS-31 elamipretide mitochondria targeted peptide aging research

SS-31 (Elamipretide, also known as MTP-131 or Bendavia) is a mitochondria-targeted tetrapeptide that has produced some of the most striking results in aging and mitochondrial biology research. Its unique mechanism — selectively concentrating in the inner mitochondrial membrane to stabilize cardiolipin — gives it direct access to the most critical organelle in cellular energy production and aging biology.

What Is SS-31?

SS-31 is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) belonging to the Szeto-Schiller (SS) peptide class developed by Hazel Szeto at Weill Cornell Medical College. Its distinctive structure — alternating aromatic and basic amino acids — gives it a strong positive charge that drives selective accumulation in the inner mitochondrial membrane (approximately 1000-fold concentration relative to cytoplasm), where it interacts with and stabilizes cardiolipin.

Mechanism: Cardiolipin Stabilization

Mitochondrial membrane cardiolipin electron transport aging

What Is Cardiolipin? Cardiolipin is a unique phospholipid found almost exclusively in the inner mitochondrial membrane. It is essential for the structural integrity and function of the electron transport chain (ETC) complexes — particularly Complex I, III, and IV — and for cytochrome c retention. With aging, disease, and oxidative stress, cardiolipin is oxidized and its structure is disrupted, leading to ETC dysfunction, cytochrome c release (triggering apoptosis), and mitochondrial fragmentation.

SS-31’s Action: SS-31 binds cardiolipin directly, preventing its oxidation and maintaining its structural integrity. This preserves ETC complex organization, maintains cytochrome c retention, reduces electron leak and ROS production, and restores the proton gradient driving ATP synthesis.

Cristae Preservation: Cardiolipin stabilization maintains the tight folding of inner mitochondrial membrane cristae — the structural arrangement that maximizes ETC efficiency. Aged and diseased mitochondria show cristae disruption; SS-31 treatment restores cristae architecture.

Key Research Findings

Aging and Skeletal Muscle

Landmark research by Bharat Bhanu’s group demonstrated that a single dose of SS-31 in aged mice restored mitochondrial cristae structure, improved ATP production, enhanced exercise capacity, and — remarkably — restored age-related declines in muscle force generation to near-young levels within hours. This rapid restoration implied that the functional decline of aged muscle mitochondria is not due to irreversible damage but to reversible cardiolipin oxidation.

Heart Failure

SS-31 (as Bendavia/Elamipretide) advanced to Phase II clinical trials in heart failure with reduced ejection fraction (HFrEF). The PROGRESS-HF trial demonstrated improved cardiac function metrics. Research in ischemia-reperfusion injury models consistently shows SS-31 reduces infarct size, preserves cardiac function, and improves survival.

Kidney Disease

Multiple studies demonstrate SS-31 protects against acute kidney injury (AKI) from ischemia-reperfusion, cisplatin toxicity, and contrast-induced nephropathy — by preserving tubular cell mitochondrial function.

Neurodegenerative Disease Models

SS-31 has been studied in Alzheimer’s, Parkinson’s, ALS, and retinal degeneration models, consistently showing neuroprotective effects through mitochondrial preservation.

SS-31 and the Mitochondrial Aging Hypothesis

SS-31’s research profile directly supports the mitochondrial theory of aging: that age-related functional decline is driven by mitochondrial dysfunction. The finding that a single SS-31 dose can rapidly reverse age-related mitochondrial dysfunction — without gene therapy, prolonged treatment, or stem cell intervention — suggests that much of the functional decline of aging may be more reversible than previously thought.

Conclusion

SS-31’s unique cardiolipin-targeting mechanism, rapid restoration of aged mitochondrial function, and clinical trial data across multiple disease indications make it one of the most scientifically compelling mitochondria-targeted therapeutics in development. For researchers studying aging biology, cardiac function, kidney disease, or mitochondrial physiology, SS-31 is an essential research compound. Combat Research provides research-grade SS-31 for qualified research applications.

Shop SS-31 at Combat Research

SS-31 10mg →


Related Research Articles

For research purposes only. Not for human therapeutic use.

Facebook
Twitter
LinkedIn
Picture of Taylor

Taylor

Leave a Reply

Your email address will not be published. Required fields are marked *

0